Clinical Trial Update: Immunogenicity and Safety of Two Formulations of GSK Biologicals' Pneumococcal Vaccine (2830929A and 2830930A) When Administered in Healthy Infants [Phase 2]

View source ↗

Summary

Phase 2 trial assessing immunogenicity and safety of two formulations of GSK Pneumococcal Vaccine in healthy infants; results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Infections
• Streptococcal Infections

Drugs mentioned

• Pneumococcal Vaccine (GSK 2830929A and 2830930A)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Streptococcal | Phase 2 | Status: COMPLETED | Results posted: 2014-06-16